BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33882792)

  • 21. Can we ablate liver lesions close to large portal and hepatic veins with MR-guided HIFU? An experimental study in a porcine model.
    Carling U; Barkhatov L; Reims HM; Storås T; Courivaud F; Kazaryan AM; Halvorsen PS; Dorenberg E; Edwin B; Hol PK
    Eur Radiol; 2019 Sep; 29(9):5013-5021. PubMed ID: 30737565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility of Magnetic Resonance-Guided High-Intensity-Focused Ultrasound (MRgHIFU) Ablation of Stump Neuromas for the Relief of Chronic Postamputation Neuropathic Pain.
    Nachtigal A; Cozakov R; Grinfeld A; Haddad M; Eisenberg E
    J Ultrasound Med; 2022 Dec; 41(12):3119-3124. PubMed ID: 35633227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome of MR-guided focused ultrasound treatment and laparoscopic myomectomy for symptomatic uterine fibroid tumors.
    Mohr-Sasson A; Machtinger R; Mashiach R; Nir O; Inbar Y; Maliyanker N; Goldenberg M; Rabinovici J
    Am J Obstet Gynecol; 2018 Oct; 219(4):375.e1-375.e7. PubMed ID: 30217580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-ever Clinical Experience With Magnetic Resonance-based Lattice Radiotherapy for Treating Bulky Gynecological Tumors.
    Ferini G; Valenti V; Viola A; Umana GE; Illari SI; Parisi S; Pontoriero A; Pergolizzi S
    Anticancer Res; 2022 Sep; 42(9):4641-4646. PubMed ID: 36039437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of magnetic resonance imaging-guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to uterus.
    Zhang L; Chen WZ; Liu YJ; Hu X; Zhou K; Chen L; Peng S; Zhu H; Zou HL; Bai J; Wang ZB
    Eur J Radiol; 2010 Feb; 73(2):396-403. PubMed ID: 19108974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targetability of cervical cancer by magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU)-mediated hyperthermia (HT) for patients receiving radiation therapy.
    Zhu L; Huang Y; Lam D; Gach HM; Zoberi I; Hallahan DE; Grigsby PW; Chen H; Altman MB
    Int J Hyperthermia; 2021; 38(1):498-510. PubMed ID: 33757406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced Pancreatic Cancer: High-Intensity Focused Ultrasound (HIFU) and Other Local Ablative Therapies.
    Marinova M; Wilhelm-Buchstab T; Strunk H
    Rofo; 2019 Mar; 191(3):216-227. PubMed ID: 30703824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility Study on MR-Guided High-Intensity Focused Ultrasound Ablation of Sciatic Nerve in a Swine Model: Preliminary Results.
    Kaye EA; Gutta NB; Monette S; Gulati A; Loh J; Srimathveeravalli G; Ezell PC; Erinjeri JP; Solomon SB; Maybody M
    Cardiovasc Intervent Radiol; 2015 Aug; 38(4):985-92. PubMed ID: 26040256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transrectal high-intensity focused ultrasound (HIFU) for management of rectosigmoid deep infiltrating endometriosis: results of Phase-I clinical trial.
    Philip CA; Warembourg S; Dairien M; Lefevre C; Gelet A; Chavrier F; Guillen N; Tonoli H; Maissiat E; Lafon C; Dubernard G
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):431-442. PubMed ID: 31788875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-intensity focused ultrasound (HIFU) for pancreatic carcinoma: evaluation of feasibility, reduction of tumour volume and pain intensity.
    Marinova M; Rauch M; Mücke M; Rolke R; Gonzalez-Carmona MA; Henseler J; Cuhls H; Radbruch L; Strassburg CP; Zhang L; Schild HH; Strunk HM
    Eur Radiol; 2016 Nov; 26(11):4047-4056. PubMed ID: 26886904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twelve-month prostate volume reduction after MRI-guided transurethral ultrasound ablation of the prostate.
    Bonekamp D; Wolf MB; Roethke MC; Pahernik S; Hadaschik BA; Hatiboglu G; Kuru TH; Popeneciu IV; Chin JL; Billia M; Relle J; Hafron J; Nandalur KR; Staruch RM; Burtnyk M; Hohenfellner M; Schlemmer HP
    Eur Radiol; 2019 Jan; 29(1):299-308. PubMed ID: 29943185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial.
    Ghai S; Perlis N; Lindner U; Hlasny E; Haider MA; Finelli A; Zlotta AR; Kulkarni GS; van der Kwast TH; McCluskey SA; Kucharczyk W; Trachtenberg J
    Eur Radiol; 2018 Oct; 28(10):4281-4287. PubMed ID: 29696431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: role of apparent diffusion coefficient (ADC) and dynamic contrast enhanced (DCE) MRI in the assessment of clinical outcome.
    Anzidei M; Napoli A; Sacconi B; Boni F; Noce V; Di Martino M; Saba L; Catalano C
    Radiol Med; 2016 Dec; 121(12):905-915. PubMed ID: 27567615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility, acceptability and effects of multimodal pelvic floor physical therapy for gynecological cancer survivors suffering from painful sexual intercourse: A multicenter prospective interventional study.
    Cyr MP; Dumoulin C; Bessette P; Pina A; Gotlieb WH; Lapointe-Milot K; Mayrand MH; Morin M
    Gynecol Oncol; 2020 Dec; 159(3):778-784. PubMed ID: 33010968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Quality of Life Outcomes Following Palliative Treatment of Bone Metastases with Magnetic Resonance-guided High Intensity Focused Ultrasound: An International Multicentre Study.
    Harding D; Giles SL; Brown MRD; Ter Haar GR; van den Bosch M; Bartels LW; Kim YS; Deppe M; deSouza NM
    Clin Oncol (R Coll Radiol); 2018 Apr; 30(4):233-242. PubMed ID: 29317145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance-guided shielding of prefocal acoustic obstacles in focused ultrasound therapy: application to intercostal ablation in liver.
    Salomir R; Petrusca L; Auboiroux V; Muller A; Vargas MI; Morel DR; Goget T; Breguet R; Terraz S; Hopple J; Montet X; Becker CD; Viallon M
    Invest Radiol; 2013 Jun; 48(6):366-80. PubMed ID: 23344514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of MRI-guided high intensity focused ultrasound treatment for adenomyosis.
    Fan TY; Zhang L; Chen W; Liu Y; He M; Huang X; Orsi F; Wang Z
    Eur J Radiol; 2012 Nov; 81(11):3624-30. PubMed ID: 21719223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.
    Chin JL; Billia M; Relle J; Roethke MC; Popeneciu IV; Kuru TH; Hatiboglu G; Mueller-Wolf MB; Motsch J; Romagnoli C; Kassam Z; Harle CC; Hafron J; Nandalur KR; Chronik BA; Burtnyk M; Schlemmer HP; Pahernik S
    Eur Urol; 2016 Sep; 70(3):447-55. PubMed ID: 26777228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility of T2 relaxation time in predicting the technical outcome of MR-guided high-intensity focused ultrasound treatment of uterine fibroids.
    Sainio T; Saunavaara J; Komar G; Otonkoski S; Joronen K; Viitala A; Perheentupa A; Blanco Sequeiros R
    Int J Hyperthermia; 2021; 38(1):1384-1393. PubMed ID: 34542013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Portable ultrasound-guided high-intensity focused ultrasound with functions for safe and rapid ablation: prospective clinical trial for uterine fibroids-short-term and long-term results.
    Lee JY; Chung HH; Kang SY; Park EJ; Park DH; Son K; Han JK
    Eur Radiol; 2020 Mar; 30(3):1554-1563. PubMed ID: 31705252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.